Top Robotics & Automation Companies Hiring

Discover manufacturers, system integrators, and innovators hiring robotics talent globally

Showing 24 of 1521 companies (Page 51 of 64)

STA Pharmaceutical logo

STA Pharmaceutical

Subsidiary of WuXi AppTec
Industrial Manufacturing Healthcare & Life Sciences

STA Pharmaceutical Co., Ltd., a WuXi AppTec company (WuXi STA), is a global leading small molecule pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with operations in China and the United States. As a premier Contract Development and Manufacturing Organization (CDMO), STA offers our worldwide partners efficient, flexible and high-quality solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms. As the world’s largest process chemistry organization, our highly skilled 1,000+ research scientists will help you to solve a wide range of challenges such as: Route scouting Process development, optimization and scale-up Develop control strategy for Regulatory Starting Materials (RSMs), intermediates and APIs Process validations Our state-of-the-art manufacturing facilities are capable of producing advanced intermediates and innovative APIs under cGMP from kilo to metric ton scale. Large Capacity: 400m3 reactor volume in Shanghai Jinshan site, adding 1,000+ m3 reactor volume in newly opened Changzhou site. Overall our customers have access to 200 reactors ranging from 5 L to 20,000 L which ensure shorter production lead time. Global Standard Quality System: our Shanghai Jinshan production site has been approved by 8 global regulatory agencies to produce innovative APIs and advanced intermediates: U.S. FDA, CFDA, EMA, Australia TGA, Health Canada, Japanese MHLW, Swiss medic, New Zealand MPI. Our cutting-edge drug product R&D and manufacturing facility in Shanghai offers formulation research development from preclinical to commercial as well as the clinical batches manufacturing, packaging and labeling. Fast IND enabling developability assessment studies integrated with WuXi AppTec medicinal chemistry, DMPK and biology units Expertise in developing low soluble drugs and pediatric formulations Experienced in manufacturing clinical supplies for oral solid dosages

WuXi AppTec logo

WuXi AppTec

Public Company
Industrial Manufacturing Healthcare & Life Sciences

Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services. WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry. 药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。 十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。 从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。

AUO Corporation America logo

AUO Corporation America

Public Company
Automotive Manufacturing System Integration

AUO Mobility Solutions Corporation America is the home of AUO's mobility solutions group for North America. AUO is a global leader for display solutions in every major industry, and AUO Mobility Solutions is leading the way in tapping into the possibilities for mobility applications. AUO generated $7.9B USD in sales revenue in 2022 and employs more than 38,000 throughout its global operations spreading across the United States, Taiwan, China, Germany, the Netherlands, Vietnam, Singapore, Japan, and South Korea. AUO’s complete line-up of Gen 3.5 to 8.5 production lines provides a full range of panel sizes and a rock-solid foundation for our integration capabilities. We provide software and hardware system integration, customized products for any shape, size, or diversity, rigorous commitment to quality, and smart services to create even greater value with our customers. AUO has world-class capability in R&D and an extensive patent portfolio, with more than 18,700 global patents approved to date. "Commit to Care" is one of our core values at AUO. We always care how we can reach a mutually beneficial goal that brings value not just to our partners, but also to culture, the environment, and society at large. We embrace the highest standards in corporate governance, environmental sustainability, and social concern, including being selected to the Dow Jones Sustainability Index (DJSI) for 13 consecutive years. Reach out to AUO and let's Tap Into The Possibilities, together.